Physician
Pathology
Dr. Edward D. Gomperts, MD
|
|
Give Review
Edward Gomperts works in the field of Pathology. He has 1 awards "Super Doctor". Edward D. Gomperts is also published. He has 99 publications published. The lastest publication: "Measurement of active coagulation factors in Autoplex-T with colorimetric active site-specific assay technology.'
Publications
- Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.
- F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.
- Virologic and clinical features of primary infection with human parvovirus 4 in subjects with Hemophilia: frequent transmission by virally inactivated clotting factor ...
- Genome-wide association study implicates PARD3B-based AIDS restriction.
- Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection.
- Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.
- High frequencies of exposure to the novel human parvovirus PARV4 in Hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
- Quantitation of anti-factor VIII antibodies in human plasma.
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients.
- Rapid infusion of intraVenous immunoglobulin in patients with neuromuscular diseases.
- A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors.
- Long-term major joint outcomes in young adults with haemophilia: interim data from the HGDS.
- Diminished frequency of hepatitis C virus specific interferon gamma secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients.
- Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter A...
- Epitope specificity and functional characterization of factor VIII inhibitors.
- Relation between HIV-1 and hepatitis C viral load in patients with Hemophilia.
- Hepatitis C virus infection and neurocognitive function.
- Pharmacokinetic in vivo comparison using 1-stage and chromogenic substrate assays with two formulations of Hemofil-M.
- Use of fibrin sealant in thermal injury.
- Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study...
- Measurement of active Coagulation factors in Autoplex-T with colorimetric active site-specific assay technology.
- Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in Hemophiliacs. Hemophilia Growth and Development...
- Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation.
- Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay.
- Effects of high-dose intraVenous immunoglobulin on virus load in HIV-infected children.
- Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in Hemophiliacs.
- Correction of antigen-specific T-lymphocyte function by recombinant cytokines in children infected with human immunodeficiency virus type 1.
- The manufacturing process of recombinant factor VIII, recombinate.
- Treatment of Hemophilia A with a highly purified factor VIII concentrate prepared by anti-FVIIIc immunoaffinity chromatography.
- Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy.
- Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM).
- HIV and hemophilic children's growth.
- Lymphocyte phenotype does not predict Immune function in pediatric patients infected with human immunodeficiency virus type 1.
- Continuous infusion of low-dose urokinase in the treatment of central Venous catheter thrombosis in infants and children.
- Investigational use of tissue plasminogen activator (t-PA) for occluded central Venous catheters.
- Type IIA von Willebrand disease with apparent recessive inheritance.
- Comparative evaluation of the bone marrow by the volumetric method, particle smears, and biopsies in pediatric Disorders.
- A comparison of HIV antibody and HIV viral findings in blood and saliva of HIV antibody-positive juvenile Hemophiliacs.
- Glucose-6-phosphate dehydrogenase Johannesburg: a new variant with reduced activity in a patient with congenital non-spherocytic haemolytic anaemia.
- Von Willebrand''s disease in the Bantu.
- Haemophilia in the Bantu: report of 67 cases.
- Inhibitory effects of interferon on mouse megakaryocytic progenitor cells in culture.
- Overview of Hemophilia.
- Kasabach-Merritt syndrome treated by therapeutic embolization with polyvinyl alcohol.
- Selection of replacement therapy for patients with severe factor VII deficiency.
- A multicenter study of viral hepatitis in a United States hemophilic population.
- Recombinate study.
- Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 i...
- Resistance of porcine circovirus and chicken Anemia virus to virus inactivation procedures used for blood products.
- HIV-1 pol replication capacity predicts disease progression.
- Longitudinal analysis of CD8 T-cell responses to HIV and hepatitis C virus in a cohort of co-infected haemophiliacs.
- Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression.
- The next generation of Hemophilia treatment specialists.
- Platelet count is associated with plasma HIV type 1 RNA and disease progression.
- From theory to practice: applying current clinical knowledge and treatment strategies to the care of Hemophilia a patients with inhibitors.
- Baseline HIV type 1 coreceptor tropism predicts disease progression.
- Delays in maturation among adolescents with Hemophilia and a history of inhibitors.
- Antibodies to heterologous proteins in Hemophilia A patients receiving recombinant factor VIII (Recombinate).
- Ethics of AIDS study.
- Potency and mass of factor VIII in FVIII products.
- von Willebrand factor: what is its role in the Immune response in haemophilia?
- Frequency and causes of hospitalization in HIV-negative children and adolescents with haemophilia A or B and its effect on academic achievement.
- Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method. Proceedings of a Special Symposium at the X...
- Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate): a prospective pharmacovigilance study.
- Defining the impact of Hemophilia: the Academic Achievement in Children with Hemophilia Study.
- Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events.
- Gammagard and reported hepatitis C virus episodes.
- Haemophilia-related morbidity and quality-of-life.
- Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods.
- The need for previously untreated patient population studies in understanding the development of factor VIII inhibitors.
- The parachute must be properly folded ...
- A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients.
- The effect of plasma human immunodeficiency virus RNA and CD4(+) T lymphocytes on growth measurements of hemophilic boys and adolescents.
- Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: a randomized clinical trial.
- Prevalence and incidence of intracranial haemorrhage in a population of children with haemophilia. The Hemophilia Growth and Development Study.
- Comparison of high responder inhibitor frequency in recent studies of previously untreated patients with Hemophilia A.
- Hemophilia morbidity, cognitive functioning, and academic achievement.
- A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with Hemophilia A. The Recombinate Previously Treated Patient Study Group.
- Prospective, randomized evaluation of the efficacy of fibrin sealant as a topical hemostatic agent at the cannulation site in neonates undergoing extracorporeal membra...
- Homocystinuria: clinical and pathologic review, with emphasis on thrombotic features, including pulmonary artery thrombosis.
- A note on the calculation of recovery for factor VIII infusions.
- Response to commercial factor VIII concentrate.
- Hemophilia growth and development study. Design, methods, and entry data.
- Anaphylaxis after treatment with recombinant factor VIII.
- HCV and Gammagard in France.
- A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with Hemophilia A. The Recombinate ...
- Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents. Hemophilia Growth and Development Study Group.
- Delayed somatic growth and pubertal development in human immunodeficiency virus-infected Hemophiliac boys: Hemophilia Growth and Development Study.
- A clinical evaluation of genetic stability.
- Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentrates.
- Hepatocellular enzyme patterns and hepatitis B virus exposure in multitransfused young and very young Hemophilia patients.
- Dialysis and renal transplant in a Hemophiliac.
- Circulating immune complexes pre and post clotting factor infusion in Hemophilia.
- Abnormal T-cell subsets and mitogen responses in Hemophiliacs exposed to factor concentrate.
- Use of activated prothrombin complex concentrate over multiple surgical episodes in a hemophilic child with an inhibitor.
- Antithrombin III progressive function: a biochemical analysis.
- Induction of tolerance to factor VIII in a child with a high-titer inhibitor: in vitro and in vivo observations.
- Pyknocytosis in heat-stroke.
Conditions Treated
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Hemophilia
- Hypercoagulable State
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
Awards
- Super Doctor
Hospital
-
Children's Hospital Los Angeles
Helpful Reviews
Similar Doctors
|
|
Dr. Christine A. Wheeler, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary J. Schiller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pouneh Beizai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian Kwok, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Youn C. Kim, MD |
|
|
Dr. Thomas T. Noguchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Franklin Sedarat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason P. Tovar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ilene C. Weitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven Yea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heinz Lenz, MD |
|
|
Dr. Carol K. Kasper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander Shar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Giridharan Ramsingh, MD
This Doctor is OpenDoctor Recommended.
|